Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Davids et al v. Novartis Pharmaceuticals Corporation
Case Number:
2:06-cv-00431
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
October 11, 2013
$9M Shaved From Novartis Jaw Injury Award By NY Judge
A New York judge on Wednesday denied Novartis Pharmaceuticals Corp.'s bid for a mistrial declaration in litigation over jaw deterioration injuries purportedly linked to bone drug Zometa, but slashed a $10 million punitive damage award to just less than $1 million.
-
November 05, 2012
Novartis Smacked With $10.5M Verdict In Jaw Injury Suit
A New York federal jury hit Novartis Pharmaceuticals Corp. with a $10.5 million verdict Friday in a suit brought by a woman whose jaw deteriorated after she took the bone drug Zometa, snapping a string of victories for the company in multidistrict litigation over the drug.